Drug development in Alzheimer’s disease: the path to 2025
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13195-016-0207-9
Published Online: 2016-09-20
Published Print: 2016-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Cummings, Jeffrey
Aisen, Paul S.
DuBois, Bruno
Frölich, Lutz
Jack, Clifford R. Jr
Jones, Roy W.
Morris, John C.
Raskin, Joel
Dowsett, Sherie A.
Scheltens, Philip
Text and Data Mining valid from 2016-09-20
Version of Record valid from 2016-09-20
Article History
First Online: 20 September 2016